Literature DB >> 18648841

German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye.

Carl Erb1, Ulrike Gast, Dieter Schremmer.   

Abstract

BACKGROUND: The purpose of this register was to determine the links between glaucoma, age, concomitant disease, medication, and dry eye in a large group of glaucoma patients.
METHODS: A total of 20,506 patients from 900 centers across Germany were included. The first 30 consecutive glaucoma patients at each center were recruited. Epidemiological data as well as information on glaucoma, medication, concomitant diseases, dry eye, and local symptoms were elicited by means of a questionnaire. We analyzed primary open-angle glaucoma (POAG), pseudoexfoliation glaucoma (PEX), and pigmentary glaucoma (PDG).
RESULTS: According to the register data, more women develop dry eye and glaucoma than men (56.9 vs. 45.7%). The most frequent concomitant systemic diseases were hypertension (48.1%), diabetes mellitus (22.5%), and dry mouth, nose, and skin (11.3%). As expected, the highest incidence of dry eye was found in those patients with dry mouth, nose, and skin. Dry eye occurred with dissimilar frequencies in association with the various glaucoma types: PEX>POAG>PDG. The incidence of dry eye increases with age. The gender difference in the occurrence of dry eye becomes apparent from the age of 50. Dry eye occurred more frequently when three or more antiglaucoma drugs were used and increased with the duration of glaucoma disease.
CONCLUSIONS: We publish the first results from the German Glaucoma and Dry Eye Register. We found that the occurrence of dry eye is linked to several factors. Thus, the type of glaucoma has an impact on the risk of dry eye. The quantity of eye drops applied also plays a role in the development of the dry eye syndrome if more than three medications are used. While POAG is usually treated with one drug, PEX and PDG tend to be treated with multiple drugs. The gender difference in the occurrence of dry eye becomes apparent from the age 50 years. Because of the vicious circle of dry eye, antiglaucoma eye drops containing benzalkonium chloride compromises patient compliance. The results of the register are therefore of key relevance for the care of glaucoma patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18648841     DOI: 10.1007/s00417-008-0881-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  37 in total

1.  Basal tear turnover and topical timolol in glaucoma patients and healthy controls by fluorophotometry.

Authors:  E V Kuppens; T R Stolwijk; R J de Keizer; J A van Best
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-11       Impact factor: 4.799

2.  The Framingham Eye Study. I. Outline and major prevalence findings.

Authors:  H A Kahn; H M Leibowitz; J P Ganley; M M Kini; T Colton; R S Nickerson; T R Dawber
Journal:  Am J Epidemiol       Date:  1977-07       Impact factor: 4.897

3.  Tear meniscus measurement in the diagnosis of dry eye.

Authors:  J C Mainstone; A S Bruce; T R Golding
Journal:  Curr Eye Res       Date:  1996-06       Impact factor: 2.424

4.  Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.

Authors:  J M Tielsch; A Sommer; J Katz; R M Royall; H A Quigley; J Javitt
Journal:  JAMA       Date:  1991-07-17       Impact factor: 56.272

Review 5.  Ophthalmologic manifestations of rheumatic diseases.

Authors:  F Hamideh; P E Prete
Journal:  Semin Arthritis Rheum       Date:  2001-02       Impact factor: 5.532

6.  Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man.

Authors:  W S Wilson; A J Duncan; J L Jay
Journal:  Br J Ophthalmol       Date:  1975-11       Impact factor: 4.638

7.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

8.  Corneal and conjunctival changes caused by commonly used glaucoma medications.

Authors:  Robert J Noecker; Lisa A Herrygers; Raana Anwaruddin
Journal:  Cornea       Date:  2004-07       Impact factor: 2.651

9.  Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.

Authors:  D C Broadway; I Grierson; C O'Brien; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1994-11

Review 10.  Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007).

Authors: 
Journal:  Ocul Surf       Date:  2007-04       Impact factor: 5.033

View more
  49 in total

1.  Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial.

Authors:  Arthur Shedden; Ingrid A Adamsons; Albert J Getson; Jean K Laurence; Christopher R Lines; David J Hewitt; Tony W Ho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

2.  [Glaucoma and dry eye. Current concepts and future perspectives].

Authors:  P Steven; C Cursiefen
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

3.  Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders.

Authors:  Jack Stringham; Noy Ashkenazy; Anat Galor; Sarah R Wellik
Journal:  Eye Contact Lens       Date:  2018-01       Impact factor: 2.018

4.  [Increased treatment costs through use of nonpreserved antiglaucoma agents?].

Authors:  S Schneider
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

Review 5.  [PEX syndrome. Clinical diagnosis and systemic manifestations].

Authors:  E Scharfenberg; U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

6.  [Importance of perimetric differential diagnostics in patients with primary open-angle glaucoma].

Authors:  C Erb; K Göbel
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

Review 7.  [Diagnosis and therapy of pseudoexfoliation glaucoma].

Authors:  A G M Jünemann
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

8.  [Current developments in minimally invasive glaucoma surgery].

Authors:  C Erb
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

9.  Evaluation of ocular surface disease in patients with glaucoma.

Authors:  Priya M Mathews; Pradeep Y Ramulu; David S Friedman; Canan A Utine; Esen K Akpek
Journal:  Ophthalmology       Date:  2013-05-25       Impact factor: 12.079

10.  Analysis of the effects of preservative-free tafluprost on the tear proteome.

Authors:  Sebastian Funke; Sabine Beck; Katrin Lorenz; Marion Kotterer; Dominik Wolters; Natarajan Perumal; Norbert Pfeiffer; Franz H Grus
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.